254 related articles for article (PubMed ID: 7588997)
1. Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma.
Simmons RB; Newton GR; Doctor VM
Eur J Drug Metab Pharmacokinet; 1995; 20(1):73-7. PubMed ID: 7588997
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of potentiation of antithrombin III and heparin cofactor II inhibition by sulfated xylans.
Carson L; Doctor VM
Thromb Res; 1990 May; 58(4):367-81. PubMed ID: 1972302
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of potentiation of antithrombin III [AT-III] inhibition by sulfated xylans.
Campbell A; Nesheim ME; Doctor VM
Thromb Res; 1987 Aug; 47(3):341-52. PubMed ID: 2442830
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate.
Sié P; Fernandez F; Caranobe C; Gabaig AM; Boneu B
Thromb Res; 1984 Jul; 35(2):231-6. PubMed ID: 6206589
[No Abstract] [Full Text] [Related]
6. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence and circular dichroism studies during the interactions of sulfated polysaccharides with antithrombin III.
Tanyi A; Benjamin V; Sadberry AJ; Doctor VM
Thromb Res; 1995 Mar; 77(6):505-13. PubMed ID: 7542805
[TBL] [Abstract][Full Text] [Related]
8. Comparative turn-over of heparin cofactor II and antithrombin III in baboons. Influence of heparin and pentosan polysulfate administration.
Sié P; Lansen J; Lacheretz F; Verschuere B; Boneu B
Thromb Haemost; 1986 Dec; 56(3):302-7. PubMed ID: 2436331
[TBL] [Abstract][Full Text] [Related]
9. Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54).
Scully MF; Kakkar VV
Thromb Res; 1984 Oct; 36(2):187-94. PubMed ID: 6209821
[TBL] [Abstract][Full Text] [Related]
10. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
[TBL] [Abstract][Full Text] [Related]
11. Selective activation of heparin cofactor II by a sulfated polysaccharide isolated from the leaves of Artemisia princeps.
Hayakawa Y; Hayashi T; Hayashi T; Niiya K; Sakuragawa N
Blood Coagul Fibrinolysis; 1995 Oct; 6(7):643-9. PubMed ID: 8562835
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin.
Church FC; Meade JB; Treanor RE; Whinna HC
J Biol Chem; 1989 Feb; 264(6):3618-23. PubMed ID: 2914965
[TBL] [Abstract][Full Text] [Related]
13. Heparin cofactor II-dependent antithrombin activity of calcium spirulan.
Hayakawa Y; Hayashi T; Hayashi K; Hayashi T; Ozawa T; Niiya K; Sakuragawa N
Blood Coagul Fibrinolysis; 1996 Jul; 7(5):554-60. PubMed ID: 8874866
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of thrombin inhibition by heparin cofactor II in the presence of dermatan sulphates, native or oversulphated, and a heparin-like dextran derivative.
Maaroufi RM; Jozefowicz M; Tapon-Bretaudière J; Jozefonvicz J; Fischer AM
Biomaterials; 1997 Feb; 18(4):359-66. PubMed ID: 9068899
[TBL] [Abstract][Full Text] [Related]
15. Binding of heparin or dermatan sulfate to thrombin is essential for the sulfated polysaccharide-accelerated inhibition of thrombin by heparin cofactor II.
Yamagishi R; Koide T; Sakuragawa N
FEBS Lett; 1987 Dec; 225(1-2):109-12. PubMed ID: 3691797
[TBL] [Abstract][Full Text] [Related]
16. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparin.
Liaw PC; Becker DL; Stafford AR; Fredenburgh JC; Weitz JI
J Biol Chem; 2001 Jun; 276(24):20959-65. PubMed ID: 11294849
[TBL] [Abstract][Full Text] [Related]
18. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
[TBL] [Abstract][Full Text] [Related]
19. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans.
Yamagishi R; Niwa M; Kondo S; Sakuragawa N; Koide T
Thromb Res; 1984 Dec; 36(6):633-42. PubMed ID: 6084876
[TBL] [Abstract][Full Text] [Related]
20. Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thrombin-heparin cofactor II complex.
Preissner KT; Sié P
Thromb Haemost; 1988 Dec; 60(3):399-406. PubMed ID: 2976993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
